Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Figure S9 from JAB-3312, a Potent Allosteric SHP2 Inhibitor That Enhances the Efficacy of RTK/RAS/MAPK and PD-1 Blockade Therapies
  1. Home
  2. Publications
  3. Supplementary Figure S9 from JAB-3312, a Potent Allosteric SHP2 Inhibitor That Enhances the Efficacy of RTK/RAS/MAPK and PD-1 Blockade Therapies

Supplementary Figure S9 from JAB-3312, a Potent Allosteric SHP2 Inhibitor That Enhances the Efficacy of RTK/RAS/MAPK and PD-1 Blockade Therapies

Authors:
  • DKDi Kang
    Di Kang
  • YWYanping Wang
    Yanping Wang
  • YLYiwei Lin
    Yiwei Lin
  • WMWen Wee Ma
    Wen Wee Ma
  • DMDaniel Morgensztern
    Daniel Morgensztern
  • KLKonstantinos Leventakos
    Konstantinos Leventakos
  • CBChao Bi
    Chao Bi
  • YDYuli Ding
    Yuli Ding
  • JXJing Xiong
    Jing Xiong
  • MYMan Yan
    Man Yan
  • XSXin Sun
    Xin Sun
  • PWPeng Wang
    Peng Wang

Open Access
Publisher website
Google Scholar
  • 15 July 2025
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1078-0432.29568188
Abstract
Supplementary Figure S9. The anti-tumor activity of JAB-3312 was abrogated by CD8+ T cell depletion. A-B. Tumor growth change (A) and body weight change (B) of MC38 syngeneic model during the treatment. Mean ± SEM was shown.
Keywords
  • SUPPLEMENTARY FIGURE
  • POTENT ALLOSTERIC
  • BLOCKADE THERAPIES
  • THERAPIES SUPPLEMENTARY
  • FIGURE
  • RAS
  • SUPPLEMENTARY
  • ALLOSTERIC
  • INHIBITOR
  • RTK
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.